Introduction: Tumor markers are biochemical signs of tumor existence and consist of cell surface antibodies, cytoplasm proteins, enzymes and hormones. Patients and Method: We evaluated the variability of tumor marker levels in following-up patients without the evidence of the disease after the resection of a primary breast cancer. Carcinoemberionic antigen (CEA) and CA 15.3 were measured by commercially available method
Abstracts: The tumor marker CA15.3 is the most specific indicator of breast cancer ever known. CEA a...
Monitoring the response to treatment in relapsed breast cancer patients is one of the chief uses of ...
The aim of this study was to evaluate CEA and CA 15-3 changes in patients surgically treated for bre...
Carcinoembryonic antigen (CEA) is still a widely used test for monitoring breast cancer, although re...
Carcinoembryonic antigen (CEA) is still a widely used test for monitoring breast cancer, although re...
Carcinoembryonic antigen (CEA) is still a widely used test for monitoring breast cancer, although re...
Carcinoembryonic antigen (CEA) is still a widely used test for monitoring breast cancer, although re...
Carcinoembryonic antigen (CEA) is still a widely used test for monitoring breast cancer, although re...
Background and Aims: The utility of measuring carcinoembryonic antigen (CEA) and cancer antigen 15-3...
Serial serum Carcinoembryonic antigen (CEA) levels were measured in 150 individuals (50 patients wit...
Background: There is a need for biological prognostic indicators in breast cancer that would, alone ...
The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in pa...
The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in pa...
Background and purpose: Carcinoembryonic antigen (CEA) is used as a tumour marker in breast cancer (...
The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in pa...
Abstracts: The tumor marker CA15.3 is the most specific indicator of breast cancer ever known. CEA a...
Monitoring the response to treatment in relapsed breast cancer patients is one of the chief uses of ...
The aim of this study was to evaluate CEA and CA 15-3 changes in patients surgically treated for bre...
Carcinoembryonic antigen (CEA) is still a widely used test for monitoring breast cancer, although re...
Carcinoembryonic antigen (CEA) is still a widely used test for monitoring breast cancer, although re...
Carcinoembryonic antigen (CEA) is still a widely used test for monitoring breast cancer, although re...
Carcinoembryonic antigen (CEA) is still a widely used test for monitoring breast cancer, although re...
Carcinoembryonic antigen (CEA) is still a widely used test for monitoring breast cancer, although re...
Background and Aims: The utility of measuring carcinoembryonic antigen (CEA) and cancer antigen 15-3...
Serial serum Carcinoembryonic antigen (CEA) levels were measured in 150 individuals (50 patients wit...
Background: There is a need for biological prognostic indicators in breast cancer that would, alone ...
The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in pa...
The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in pa...
Background and purpose: Carcinoembryonic antigen (CEA) is used as a tumour marker in breast cancer (...
The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in pa...
Abstracts: The tumor marker CA15.3 is the most specific indicator of breast cancer ever known. CEA a...
Monitoring the response to treatment in relapsed breast cancer patients is one of the chief uses of ...
The aim of this study was to evaluate CEA and CA 15-3 changes in patients surgically treated for bre...